Emerging issues in traditional Chinese medicine

Canadian Journal of Physiology and Pharmacology

Volumn 83, Issue 4, 2005, Pages 321-334

  Siow, Yaw L ^a   Gong, Yuewen ^a   Au Yeung, Kathy K W ^a   Woo, Connie W H ^a   Choy, Patrick C ^a   Karmin, O ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Bioactive components; Chromatographic fingerprinting; Integration; Mechanisms; Natural Health Product (NHP) Regulations; Standardization; Traditional Chinese medicine

Indexed keywords

ADENOSINE; ARTEMISIA ANNUA EXTRACT; ARTEMISIN; BILOBALIDE; CHINESE DRUG; CHLOROQUINE; CISPLATIN; DOCETAXEL; FLOS CARTHAMI; GANODERIC ACID A; GANODERMA LUCIDUM EXTRACT; GINKGO BILOBA EXTRACT; GINKGOLIDE A; GINKGOLIDE B; HERBACEOUS AGENT; HYDROXYSAFFLOR YELLOW A; MAGNESIUM LITHOSPERMATE; PACLITAXEL; PLANT EXTRACT; QUERCETIN; RUTOSIDE; SALVIA MILTIORRHIZA EXTRACT; TANSHINONE; TAXUS CHINENSIS EXTRACT; TERPENOID DERIVATIVE; UNCLASSIFIED DRUG;

BRAIN ISCHEMIA; BREAST CANCER; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHINESE MEDICINE; CHROMATOGRAPHY; CLINICAL TRIAL; COGNITIVE DEFECT; CONGENITAL SKIN DISEASE; CORONARY ARTERY BLOOD FLOW; DEMENTIA; DRUG BIOAVAILABILITY; DRUG COST; DRUG EFFICACY; DRUG FORMULATION; DRUG INHIBITION; DRUG MANUFACTURE; DRUG MECHANISM; DRUG MONITORING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EVIDENCE BASED MEDICINE; FEVER; HEALTH CARE SYSTEM; HEALTH PROMOTION; HEART PROTECTION; HISTORY OF MEDICINE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KAPOSI SARCOMA; LUNG NON SMALL CELL CANCER; MALARIA; MEDICAL RESEARCH; NONHUMAN; OVARY CANCER; PRESCRIPTION; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SIDE EFFECT; STANDARD; THROMBOSIS; UTERUS DISEASE;

ANIMALS; CHROMATOGRAPHY; HISTORY, ANCIENT; HUMANS; MEDICINE, CHINESE TRADITIONAL; PLANTS, MEDICINAL; QUALITY CONTROL;

EID: 22044453370     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y05-029     Document Type: Review

References (191)

1. Anonymous. 1997. Shen Nong Ben Cao Jing. Liao Ning Science and Technology Press, Shen Yang. pp. 9.
2. Advisory Group on Complementary and Alternative Health Care, H.S.D., Health Canada. 2001. IV. Towards an integrative health system. In Perspectives on Complementary and Alternative Health Care: a collection of papers prepared for Health Canada. Edited by Health Canada, Ottawa. IV.a-IV.c, IV.45-IV.52.
3. Ahlemeyer, B., and Krieglstein, J. 2003. Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease. Pharmacopsychiatry, 36(Suppl. 1): S8-S14.
4. Angell, M., and Kassirer, J.P. 1998. Alternative medicine- the risks of untested and unregulated remedies. N. Engl. J. Med. 339: 839-841.
5. Annemans, L., Giaccone, G., and Vergnenegre, A. 1999. The cost-effectiveness of paclitaxel (Taxol) + cisplatin is similar to that of teniposide + cisplatin in advanced non-small cell lung cancer: a multicountry analysis. Anticancer Drugs, 10: 605-615.
6. Au-Yeung, K.K., Zhu, D.Y., O, K., and Siow, Y.L. 2001. Inhibition of stress-activated protein kinase in the ischemic/reperfused heart: role of magnesium tanshinoate B in preventing apoptosis. Biochem. Pharmacol. 62: 483-493.
7. Bao, Y., Li, C., Shen, H., and Nan, F. 2004. Determination of saikosaponin derivatives in Radix bupleuri and in pharmaceuticals of the chinese multiherb remedy xiaochaihutang using liquid chromatographic tandem mass spectrometry. Anal. Chem. 76: 4208-4216.
8. Barnes, J. 2003. Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part I. Regulation and quality. Br. J. Clin. Pharmacol. 55: 226-233.
9. Barrett, B. 2003. Alternative, complementary, and conventional medicine: is integration upon us? J. Altern. Complement. Med. 9:417-427.
10. Bastianetto, S., and Quirion, R. 2002. Natural extracts as possible protective agents of brain aging. Neurobiol. Aging 23: 891-897.
11. BBC. 2003. Prince's alternative medicine call [online]. Available from http://news.bbc.co.uk/go/pr/fr/-/1/hi/health/3049433.stm [cited 17 September 2004].
12. Bensky, D., and Gamble, A. 1993. Chinese Herbal Medicine: Materia Medica. Revised edition. In Chapter 10. Herbs that regulate the blood. Eastland Press, Inc., Seattle, pp. 267-268.
13. Bent, S., and Ko, R. 2004. Commonly used herbal medicines in the United States: a review. Am. J. Med. 116: 478-485.
14. Birks, J., Grimley, E.V., and Van Dongen, M. 2002. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst. Rev.: CD003120.
15. Boon, H. 2002. Regulation of complementary/alternative medicine: a Canadian perspective. Complement. Ther. Med. 10: 14-19.
16. Cai, Z., Lee, F.S., Wang, X.R., and Yu, W.J. 2002. A capsule review of recent studies on the application of mass spectrometry in the analysis of Chinese medicinal herbs. J. Mass Spectrom. 37: 1013-1024.
17. Cao, C., and Hu, Z. 2004. The current status of drug administration for herbal medicine in China. In First Annual Conference on the Medicinal Use of Chinese Herbs, London, Ontario, Canada.
18. Cao, L.Z., and Lin, Z.B. 2002. Regulation on maturation and function of dendritic cells by Ganoderma lucidum polysaccharides. Immunol. Lett. 83: 163-169.
19. Cao, L.Z., and Lin, Z.B. 2003. Regulatory effect of Ganoderma lucidum polysaccharides on cytotoxic T-lymphocytes induced by dendritic cells in vitro. Acta Pharmacol. Sin. 24: 321-326.
20. Cao, Q.Z., and Lin, Z.B. 2004. Antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide. Acta Pharmacol. Sin. 25: 833-838.
21. Carlton, A.L., and Bensoussan, A. 2002. Regulation of complementary medicine practitioners in Australia: Chinese medicine as a case example. Complement. Ther. Med. 10: 20-26.
22. Chan, K. 2003. Some aspects of toxic contaminants in herbal medicines. Chemosphere, 52: 1361-1371.
23. Chen, S., and Wang, L. 2003. Application and development of rRNA sequencing in origin identification of Chinese materia medica. J. Henan Univ. Chin. Med. 18: 86-88. [In Chinese.]
24. Cheng, K.F., Leung, K.S., and Leung, P.C. 2003a. Interactions between modern and Chinese medicinal drugs: a general review. Am. J. Chin. Med. 31: 163-169.
25. Cheng, Y., Chen, M., and Tong, W. 2003b. An approach to comparative analysis of chromatographic fingerprints for assuring the quality of botanical drugs. J. Chem. Inf. Comput. Sci. 43: 1068-1076.
26. Cheung, F., Siow, Y.L., and O, K. 2001. Inhibition by ginkgolides and bilobalide of the production of nitric oxide in macrophages (THP-1) but not in endothelial cells (HUVEC). Biochem. Pharmacol. 61: 503-510.
27. Coates, J.R., and Jobst, K.A. 1998. Integrated healthcare: a way forward for the next five years? A discussion document from the Prince of Wales's Initiative on Integrated Medicine. J. Altern. Complement. Med. 4: 209-247.
28. Cohen, M.M. 2004. CAM practitioners and "regular" doctors: is integration possible? Med. J. Aust. 180: 645-646.
29. Corns, C.M. 2003. Herbal remedies and clinical biochemistry. Ann. Clin. Biochem. 40: 489-507.
30. Coulter, A. 2003. Killing the goose that laid the golden egg? Br. Med. J. 326: 1280-1281.
31. Dasgupta, A. 2003. Review of abnormal laboratory test results and toxic effects due to use of herbal medicines. Am. J. Clin. Pathol. 120: 127-137.
32. de Bruyn, T. 2003. Health promotion, natural health products, and complementary and alternative health care: A background paper [online]. Available from http://www.hc-sc.gc.ca/hpfb-dgpsa/nhpd-dpsn/hp back_paper_e.pdf [cited 16 February 2004].
33. DeFeudis, F.V. 2003. A brief history of EGb 761 and its therapeutic uses. Pharmacopsychiatry, 36(Suppl. 1): S2-S7.
34. DeFeudis, F.V., and Drieu, K. 2000. Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. Curr. Drug Targets 1: 25-58.
35. DeFeudis, F.V., and Drieu, K. 2004. "Stress-alleviating" and "vigilance-enhancing" actions of Ginkgo biloba extract (EGb 761). Drug Dev. Res. 62: 1-25.
36. Di, X., Chan, K.K., Leung, H.W., and Huie, C.W. 2003. Fingerprint profiling of acid hydrolyzates of polysaccharides extracted from the fruiting bodies and spores of Lingzhi by high-performance thin-layer chromatography. J. Chromatogr. A 1018: 85-95.
37. Diamond, B., Johnson, S., Torsney, K., Morodan, J., Prokop, B., Davidek, D., and Kramer, P. 2003. Complementary and alternative medicines in the treatment of dementia: an evidence-based review. Drugs Aging, 20: 981-998.
38. DraSar, P., and Moravcova, J. 2004. Recent advances in analysis of Chinese medical plants and traditional medicines. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 812: 3-21.
39. Dwyer, J.M. 2004. Good medicine and bad medicine: science to promote the convergence of "alternative" and orthodox medicine. Med. J. Aust. 180: 647-648.
40. Edwards, R. 2004. No remedy in sight for herbal ransack. New Sci. 181: 10.
41. Eisenberg, D.M., Davis, R.B., Ettner, S.L., Appel, S., Wilkey, S., Van Rompay, M., and Kessler, R.C. 1998. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. J.A.M.A. 280: 1569-1575.
42. Ernst, E. 2000. Herbal medicines: where is the evidence? Br. Med. J. 321: 395-396.
43. Ernst, E. 2002a. Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review. J. Intern. Med. 252: 107-113.
44. Ernst, E. 2002b. Toxic heavy metals and undeclared drugs in Asian herbal medicines. Trends Pharmacol. Sci. 23: 136-139.
45. Ernst, E. 2003. Herbal medicines put into context. Br. Med. J. 327: 881-882.
46. FDA. 2004. Guidance for industry. Botanical drug products [online]. Available from http://www.fda.gov/cder/guidance/4592fnl.pdf [cited 30 September 2004].
47. Fontanarosa, P.B., and Lundberg, G.D. 1998. Alternative medicine meets science. J.A.M.A. 280: 1618-1619.
48. Fung, K.P., Wu, J., Zeng, L.H., Wong, H.N., Lee, C.M., Hon, P.M., Chang, H.M., and Wu, T.W. 1993a. Lithospermic acid B as an antioxidant-based protector of cultured ventricular myocytes and aortic endothelial cells of rabbits. Life Sci. 53: L189-L193.
49. Fung, K.P., Zeng, L.H., Wu, J., Wong, H.N.C., Lee, C.M., Hon, P.M., Chang, H.M., and Wu, T.W. 1993b. Demonstration of the myocardial salvage effect of lithospermic acid B isolated from the aqueous extract of Salvia miltiorrhiza. Life Sci. 52: PL239-PL244.
50. Gao, J.J., Min, B.S., Ahn, E.M., Nakamura, N., Lee, H.K., and Hattori, M. 2002. New triterpene aldehydes, lucialdehydes A-C, from Ganoderma lucidum and their cytotoxicity against murine and human tumor cells. Chem. Pharm. Bull. (Tokyo), 50: 837-840.
51. Gao, Y., Zhou, S., Jiang, W, Huang, M., and Dai, X. 2003. Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol. Investig. 32: 201-215.
52. Gao, J.J., Nakamura, N., Min, B.S., Hirakawa, A., Zuo, F., and Hattori, M. 2004. Quantitative determination of bitter principles in specimens of Ganoderma lucidum using high-performance liquid chromatography and its application to the evaluation of ganoderma products. Chem. Pharm. Bull. (Tokyo) 52: 688-695.
53. Ge, S., Li, G., and Ma, Z. 2003. Application of DNA fingerprinting on the identification of Chinese traditional medicine. Chin. Agri. Sci. Bull. 19: 10-15. [In Chinese.]
54. Gligorov, J., and Lotz, J.P. 2004. Preclinical pharmacology of the taxanes: implications of the differences. Oncologist, 9(Suppl. 2): 3-8.
55. Gong, C.F., and Yu, P.L. 1983. Effects of Flos carthami Co injection in the treatment of sclerema neonatorum. J. Tradit. Chin. Med. 3: 141-143.
56. Gu, J., and Liu, P. 2002. New developments in Chinese herbal authentication technology. Pharm. J. Chin. PLA 18: 223-225. [In Chinese.]
57. Gu, M., Ouyang, F., and Su, Z. 2004a. Comparison of high-speed counter-current chromatography and high-performance liquid chromatography on fingerprinting of Chinese traditional medicine. J. Chromatogr. A 1022: 139-144.
58. Gu, M., Zhang, G., Su, Z., and Ouyang, F. 2004b. Identification of major active constituents in the fingerprint of Salvia miltiorrhiza Bunge developed by high-speed counter-current chromatography. J. Chromatogr. A 1041: 239-243.
59. Hanna, G.M. 2004. NMR regulatory analysis: determination and characterization of Chinese-herb aristolochic acids. Pharmazie, 59: 170-174.
60. Health Canada. 2003. Natural Health Products Regulations. In Canada Gazette Part II. Vol. 137, No. 13, pp. 1532-1607.
61. Holliday, I. 2003. Traditional medicines in modern societies: an exploration of integrationist options through East Asian experience. J. Med. Philos. 28: 373-389.
62. Hsu, M.J., Lee, S.S., and Lin, W.W. 2002. Polysaccharide purified from Ganoderma lucidum inhibits spontaneous and Fas-mediated apoptosis in human neutrophils through activation of the phosphatidylinositol 3 kinase/Akt signaling pathway. J. Leukoc. Biol. 72: 207-216.
63. Hsu, M.J., Lee, S.S., Lee, S.T., and Lin, W.W. 2003. Signaling mechanisms of enhanced neutrophil phagocytosis and chemotaxis by the polysaccharide purified from Ganoderma lucidum. Br. J. Pharmacol. 139: 289-298.
64. Hu, H., Ahn, N.S., Yang, X., Lee, Y.S., and Kang, K.S. 2002. Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. Int. J. Cancer 102: 250-253.
65. Hyland, M.E. 2003. Methodology for the scientific evaluation of complementary and alternative medicine. Complement. Ther. Med. 11: 146-153.
66. Institute of Materia Medica. 1996. Modern research in Chinese herbal medicine. Chin.Acad.Med.Sci., Beijing Medical University and Chinese United Medical University United Publishing Company, Beijing. pp. 301-332.
67. Institute of Medicine, National Academies. 2004. Saving lives, buying time: Economics of malaria drugs in an age of resistance [online]. Available from http://www4.nationalacademies.org/news. nsf/isbn/0309092183?OpenDocument [cited 16 September 2004]
68. Itil, T.M., Eralp, E., Tsambis, E., Itil, K.Z., and Stein, U. 1996. Central nervous system effects of Ginkgo biloba, a plant extract. Am. J. Ther. 3: 63-73.
69. Jang, S.I., Jeong, S.I., Kim, K.J., Kim, H.J., Yu, H.H., Park, R., Kim, H.M., and You, Y.O. 2003. Tanshinone IIA from Salvia miltiorrhiza inhibits inducible nitric oxide synthase expression and production of TNF-alpha, IL-1beta and IL-6 in activated RAW 264.7 cells. Planta Med. 69: 1057-1059.
70. Ji, X.Y, Tan, B.K., and Zhu, YZ. 2000. Salvia miltiorrhiza and ischemic diseases. Acta Pharmacol. Sin. 21: 1089-1094.
71. Jiang, J., Slivova, V., Valachovicova, T., Harvey, K., and Sliva, D. 2004. Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3. Int. J. Oncol. 24: 1093-1099.
72. Johnston, S.R. 2004. Ovarian cancer: review of the National Institute for Clinical Excellence (NICE) guidance recommendations. Cancer Investig. 22: 730-742.
73. Jong, T.T., Lee, M.R., Hsiao, S.S., Hsai, J.L., Wu, T.S., Chiang, S.T., and Cai, S.Q. 2003. Analysis of aristolochic acid in nine sources of Xixin, a traditional Chinese medicine, by liquid chromatography/atmospheric pressure chemical ionization/tandem mass spectrometry. J. Pharm. Biomed. Anal. 33: 831-837.
74. Jordan, M.A., and Wilson, L. 2004. Microtubules as a target for anticancer drugs. Nat. Rev. Cancer, 4: 253-265.
75. Kamata, K., Iizuka, T., Nagai, M., and Kasuya, Y. 1993. Endothelium-dependent vasodilator effects of the extract from Salviae miltiorrhizae radix: A study on the identification of lithospermic acid B in the extracts. Gen. Pharmacol. 24: 977-981.
76. Kamata, K., Noguchi, M., and Nagai, M. 1994. Hypotensive effects of lithospermic acid B isolated from the extract of Salviae miltiorrhizae Radix in the rat. Gen. Pharmacol. 25: 69-73.
77. Kang, D.G., Oh, H., Chung, H.T., and Lee, H.S. 2003. Inhibition of angiotensin converting enzyme by lithospermic acid B isolated from Radix Salviae miltiorrhiza Bunge. Phytother. Res. 17: 917-920.
78. Kanowski, S., and Hoerr, R. 2003. Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial. Pharmacopsychiatry, 36: 297-303.
79. Klayman, D.L. 1985. Qinghaosu (artemisinin): an antimalarial drug from China. Science, 228: 1049-1055.
80. Le Bars, P.L. 2003. Magnitude of effect and special approach to Ginkgo biloba extract EGb 761 in cognitive disorders. Pharmacopsychiatry, 36 (Suppl. 1): S44-S49.
81. Lee, K.H. 2000. Research and future trends in the pharmaceutical development of medicinal herbs from Chinese medicine. Public Health Nutr. 3: 515-522.
82. Lee, S.Y., and Rhee, H.M. 1990. Cardiovascular effects of mycelium extract of Ganoderma lucidum: inhibition of sympathetic outflow as a mechanism of its hypotensive action. Chem. Pharm. Bull. (Tokyo), 38: 1359-1364.
83. Lee, S., Park, S., Oh, J.W., and Yang, C. 1998. Natural inhibitors for protein prenyltransferase. Planta Med. 64: 303-308.
84. Lei, X.L., and Chiou, G.C. 1986a. Cardiovascular pharmacology of Panax notoginseng (Burk) F.H. Chen and Salvia miltiorrhiza. Am. J. Chin. Med. 14: 145-152.
85. Lei, X.L., and Chiou, G.C. 1986b. Studies on cardiovascular actions of Salvia miltiorrhiza. Am. J. Chin. Med. 14: 26-32.
86. Leung, K.S., and Chan, K. 2004. Regulatory system of proprietary Chinese medicine in Hong Kong. J. Complement. Integ. Med. 1: 1-6.
87. Li, Y., and Che, Q. 1998. Studies on chemical components of Carthamus tinctorius petals. Acta Pharm. Sin. 33: 626-628. [In Chinese.]
88. Liang, Y.Z., Xie, P., and Chan, K. 2004. Quality control of herbal medicines. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 812: 53-70.
89. Liebgott, T., Miollan, M., Berchadsky, Y., Drieu, K., Culcasi, M., and Pietri, S. 2000. Complementary cardioprotective effects of flavonoid metabolites and terpenoid constituents of Ginkgo biloba extract (EGb 761) during ischemia and reperfusion. Basic Res. Cardiol. 95: 368-377.
90. Lin, Z.B. 2001a. The integrated studies on Ganoderma lucidum Kayst. Guided by Traditional Chinese medical theories. Chin. J. Integr. Trad. West. Med. 21: 883-884. [In Chinese.]
91. Lin, Z.B. 2001b. Modern research on Ganoderma lucidum. Beijing Medical University Press, Beijing.
92. Liu, Y.T., Murong, S.X., and Xu, G.Y. 1997. Effects of Flos carthami on beta-endorphin levels in brain regions of rats with cerebral ischemia. Chin. J. Integr. Trad. West. Med. 17: 169-170. [In Chinese.]
93. Liu, X., Yuan, J.P., Chung, C.K., and Chen, X.J. 2002. Antitumor activity of the sporoderm-broken germinating spores of Ganoderma lucidum. Cancer Lett. 182: 155-161.
94. Luo, J., and Lin, Z.B. 2001. A new triterpene from the fruiting bodies of Ganoderma lucidum. Acta Pharm. Sin. 36: 595-598. [In Chinese.]
95. Luo, J., and Lin, Z.B. 2002. Advances of pharmacological effects of triterpenes from Ganoderma lucidum. Acta Pharm. Sin. 37: 574-578. [In Chinese.]
96. Luo, J., Zhao, Y.Y., and Li, Z.B. 2002a. A new lanostane-type triterpene from the fruiting bodies of Ganoderma lucidum. J. Asian Nat. Prod. Res. 4: 129-134.
97. Luo, W.B., Dong, L., and Wang, Y.P. 2002b. Effect of magnesium lithospermate B on calcium and nitric oxide in endothelial cells upon hypoxia/reoxygenation. Acta Pharmacol. Sin. 23: 930-936.
98. Ma, R.L., Zhou, H.H., Yu, X.S., and Sheng, L.S. 2003. Study on the fingerprints of the alkaloids in Sophora flavescens. China J. Chin. Materia Med. 28: 817-819. [In Chinese.]
99. Maitra, I., Marcocci, L., Droy-Lefaix, M.T., and Packer, L. 1995. Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761. Biochem. Pharmacol. 49: 1649-1655.
100. Mau, J.L., Lin, H.C., and Chen, C.C. 2002. Antioxidant properties of several medicinal mushrooms. J. Agric. Food Chem. 50: 6072-6077.
101. McGuire, W.P. III, and Markman, M. 2003. Primary ovarian cancer chemotherapy: current standards of care. Br. J. Cancer, 89 (Suppl. 3): S3-S8.
102. McNeil, C. 1995. Semisynthetic Taxol goes on market amid ongoing quest for new versions. J. Natl. Cancer Inst. 87: 1106-1108.
103. Meselhy, M.R., Kadota, S., Hattori, M., and Namba, T. 1993. Metabolism of safflor yellow B by human intestinal bacteria. J. Nat. Prod. 56: 39-45.
104. Meshnick, S.R. 2002. Artemisinin: mechanisms of action, resistance and toxicity. Int. J. Parasitol. 32: 1655-1660.
105. Métalié, G., and Hsu, E. 2001. The Bencao gangmu of Li Shizhen: an innovation in natural history? In Innovation in Chinese medicine. Edited by E. Hsu. Cambridge University Press, Cambridge, New York. pp. 221-261.
106. Min, B.S., Gao, J.J., Nakamura, N., and Hattori, M. 2000. Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells. Chem. Pharm. Bull. (Tokyo), 48: 1026-1033.
107. Min, B.S., Gao, J.J., Hattori, M., Lee, H.K., and Kim, Y.H. 2001. Anticomplement activity of terpenoids from the spores of Ganoderma lucidum. Planta Med. 67: 811-814.
108. Nowak, A.K., Wilcken, N.R., Stockler, M.R., Hamilton, A., and Ghersi, D. 2004. Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early breast cancer. Lancet Oncol. 5: 372-380.
109. O, K., Cheung, F., Sung, F.L., Zhu, D.Y., and Siow, Y.L. 2000. Effect of magnesium tanshinoate B on the production of nitric oxide in endothelial cells. Mol. Cell. Biochem. 207: 35-39.
110. O, K., Lynn, E.G., Vazhappilly, R., Au-Yeung, K.K., Zhu, D.Y., and Siow, Y.L. 2001. Magnesium tanshinoate B (MTB) inhibits low density lipoprotein oxidation. Life Sci. 68: 903-912.
111. O'Hara, D.P. 2002. Quality controls and product standards: A research-priority setting conference [online]. Available from http://www.hc-sc.gc.ca/hpfb-dgpsa/nhpd-dpsn/quality_controls_1_e.html [cited 16 February 2004].
112. Okuda, H. 2003. Hints of western medicine from Chinese medicine. Exp. Biol. Med. (Maywood) 228: 1250-1255.
113. O'Neill, P.M., and Posner, G.H. 2004. A medicinal chemistry perspective on artemisinin and related endoperoxides. J. Med. Chem. 47: 2945-2964.
114. Ong, E.S. 2004. Extraction methods and chemical standardization of botanicals and herbal preparations. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 812: 23-33.
115. Ozols, R.F. 2004. Update on Gynecologic Oncology Group (GOG) trials in ovarian cancer. Cancer Investig. 22 (Suppl. 2): 11-20.
116. Pharmacopoeia Commission of the People Republic of China. 2000. Pharmacopoeia of People's Republic of China. Chemical Industry Press, Beijing.
117. Pirker, R., Krajnik, G., Zochbauer, S., Malayeri, R., Kneussl, M., and Huber, H. 1995. Paclitaxel/cisplatin in advanced non-small-cell lung cancer (NSCLC). Ann. Oncol. 6: 833-835.
118. Qin, H.L., Wang, Z.T., Xu, L.S., and Zhao, T.Z. 2001. Authentication of traditional Chinese herbal medicines (TCHM) by fingerprints of characteristic general constituents. China J. Chin. Mater. Med. 26: 4-9. [In Chinese.]
119. Qiu, X., Jia, X., Ye, Y., Chen, L., and Kong, L. 2003. The study on fingerprint of compound ginseng injection by powder X-ray diffraction. Chin. Materia Med. 26: 552-554. [In Chinese.]
120. Quah, S.R. 2003. Traditional healing systems and the ethos of science. Soc. Sci. Med. 57: 1997-2012.
121. Raskin, I., and Ripoll, C. 2004. Can an apple a day keep the doctor away? Curr. Pharm. Des. 10: 3419-3429.
122. Raskin, I., Ribnicky, D.M., Komarnytsky, S., Ilic, N., Poulev, A., Borisjuk, N., Brinker, A., Moreno, D.A., Ripoll, C., Yakoby, N., O'Neal, J.M., Cornwell, T., Pastor, I., and Fridlender, B. 2002. Plants and human health in the twenty-first century. Trends Biotechnol. 20: 522-531.
123. Saiki, I., Yamaura, T., Ohnishi, Y., Hayakawa, Y., Komatsu, Y., and Nunome, S. 1999. HPLC analysis of juzen-taiho-to and its variant formulations and their antimetastatic efficacies. Chem. Pharm. Bull. (Tokyo) 47: 1170-1174.
124. Satoh, A., Yokozawa, T., Cho, E.J., Okamoto, T., and Sei, Y. 2004. Antioxidative effects related to the potential anti-aging properties of the Chinese prescription Kangen-karyu and Carthami Flos in senescence-accelerated mice. Arch. Gerontol. Geriatr. 39: 69-82.
125. Schwedhelm, E., Maas, R., Troost, R., and Boger, R.H. 2003. Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stress. Clin. Pharmacokinet. 42: 437-459.
126. Seidman, A.D. 1999. Single-agent paclitaxel in the treatment of breast cancer: phase I and II development. Semin, Oncol. 26: 14-20.
127. Sengupta, S., Toh, S.A., Sellers, L.A., Skepper, J.N., Koolwijk, P., Leung, H.W., Yeung, H.W., Wong, R.N., Sasisekharan, R., and Fan, T.P. 2004. Modulating angiogenesis: the yin and the yang in ginseng. Circulation, 110: 1219-1225.
128. Shanghai Cooperative Group for the Study of Tanshinone IIA. 1984. Therapeutic effect of sodium tanshinone IIA sulfonate in patients with coronary heart disease. A double blind study. J. Tradit. Chin. Med. 4: 20-24.
129. Shao, B.M., Dai, H., Xu, W., Lin, Z.B., and Gao, X.M. 2004. Immune receptors for polysaccharides from Ganoderma lucidum. Biochem. Biophys. Res. Commun. 323: 133-141.
130. Shen, J., Wang, J., Zhao, B., Hou, J., Gao, T., and Xin, W. 1998. Effects of EGb 761 on nitric oxide and oxygen free radicals, myocardial damage and arrhythmia in ischemia-reperfusion injury in vivo. Biochim. Biophys. Acta 1406: 228-236.
131. Shiao, M.S. 2003. Natural products of the medicinal fungus Ganoderma lucidum: occurrence, biological activities, and pharmacological functions. Chem. Rec. 3: 172-180.
132. Shieh, Y.H., Liu, C.F., Huang, Y.K., Yang, J.Y., Wu, I.L., Lin, C.H., and Li, S.C. 2001. Evaluation of the hepatic and renal-protective effects of Ganoderma lucidum in mice. Am. J. Chin. Med. 29: 501-507.
133. Shiuh, S., Yau, H., Chieh, F., Sheng, Y., and Kuang, Y. 1995. Antitumor effects of Ganoderma lucidum. J. Chin. Med. 6: 1-12.
134. Simpson, D., and Plosker, G.L. 2004. Paclitaxel: as adjuvant or neoadjuvant therapy in early breast cancer. Drugs, 64: 1839-1847.
135. Siow, Y.L., Choy, P.C., Leung, W.M., and O, K. 2000. Effect of Flos carthami on stress-activated protein kinase activity in the isolated reperfused rat heart. Mol. Cell. Biochem. 207: 41-47.
136. Sliva, D. 2003. Ganoderma lucidum (Reishi) in cancer treatment. Integr. Cancer Ther. 2: 358-364.
137. Sliva, D., Labarrere, C., Slivova, V., Sedlak, M., Lloyd, F.P., Jr., and Ho, N.W. 2002. Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells. Biochem. Biophys. Res. Commun. 298: 603-612.
138. Sliva, D., Sedlak, M., Slivova, V., Valachovicova, T., Lloyd, F.P., Jr., and Ho, N.W. 2003. Biologic activity of spores and dried powder from Ganoderma lucidum for the inhibition of highly invasive human breast and prostate cancer cells. J. Altern. Complement. Med. 9: 491-497.
139. Smith, J.V., and Luo, Y. 2004. Studies on molecular mechanisms of Ginkgo biloba extract. Appl. Microbiol. Biotechnol. 64: 465-472.
140. Stebbing, J., Wildfire, A., Portsmouth, S., Powles, T., Thirlwell, C., Hewitt, P., Nelson, M., Patterson, S., Mandalia, S., Gotch, F., Gazzard, E.G., and Bower, M. 2003. Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations. Ann. Oncol. 14: 1660-6.
141. Still, J. 2003. Use of animal products in traditional Chinese medicine: environmental impact and health hazards. Complement. Ther. Med. 11: 118-122.
142. Sun, Y., Guo, T., Sui, Y., and Li, F. 2003. Fingerprint analysis of Flos carthami by capillary electrophoresis. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 792: 147-152.
143. Tao, J., and Feng, K.Y. 1990. Experimental and clinical studies on inhibitory effect of Ganoderma lucidum on platelet aggregation. J. Tongji Med. Univ. 10: 240-243.
144. Tulpule, A., Groopman, J., Saville, M.W., Harrington, W., Jr., Friedman-Kien, A., Espina, B.M., Garces, C., Mantelle, L., Mettinger, K., Scadden, D.T., and Gill, P.S. 2002. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma. Cancer, 95: 147-154.
145. van Beek, T.A. 2002. Chemical analysis of Ginkgo biloba leaves and extracts. J. Chromatogr. A 967: 21-55.
146. van Dongen, M., van Rossum, E., Kessels, A., Sielhorst, H., and Knipschild, P. 2003. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial. J. Clin. Epidemiol. 56: 367-376.
147. Veal, L. 2004. Countering misleading information. Complement. Then Nurs. Midwifery 10: 54-57.
148. von Moltke, K., and Spaninks, F. 2000. Traditional Chinese medicine and species endangerment: An economic research agenda. Working paper no. 32. International Institute for Environment and Development (IIED), London, and the Institute for Environmental Studies (IVM), Amsterdam, pp. 23.
149. von Pawel, J., Wagner, H., Niederle, N., Heider, A., Koschel, G., Gromotka, E., and Hanske, M. 1996. Paclitaxel and cisplatin in patients with non-small cell lung cancer: results of a phase II trial. Semin. Oncol. 23: 7-9.
150. Wachtel-Galor, S., Tomlinson, B., and Benzie, I.F. 2004. Ganoderma lucidum ("Lingzhi"), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study. Br. J. Nutr. 91: 263-269.
151. Wang, B.Z., Yang, M.G., Pang, L., and Yu, Z.J. 1979. Effect of Hong-Hua (Flos carthami) on the extent of myocardial ischemia in the different infarct zones following coronary occlusion in the dog (author's transl). Acta Pharm. Sin. 14: 474-479. [In Chinese.]
152. Wang, S.Y., Hsu, M.L., Hsu, H.C., Tzeng, C.H., Lee, S.S., Shiao, M.S., and Ho, C.K. 1997. The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int. J. Cancer 70: 699-705.
153. Wang, W., Wang, Y.P., Sun, W.K., Xu, Y.M., and Xuan, L.J. 2000. Effects of magnesium lithospermate B on aggregation and 5-HT release in rabbit washed platelets. Acta Pharmacol. Sin. 21: 859-863.
154. Wang, S., Wu, Y., He, L., Zheng, Q., and Lu, Y. 2003. Identification of Chinese medicinal material radix Angelicae sinensis by X-ray diffraction Fourier fingerprint pattern method. Materia Med. 26:709-711. [In Chinese.]
155. Wang, D., Liu, Z., Guo, M., and Liu, S. 2004. Structural elucidation and identification of alkaloids in Rhizoma Coptidis by electrospray ionization tandem mass spectrometry. J. Mass Spectrom. 39: 1356-1365.
156. Wani, M.C., Taylor, H.L., Wall, M.E., Coggon, P., and McPhail, A.T. 1971. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Am. Chem. Soc. 93: 2325-2327.
157. Weng, N. 2003. Bioanalytical liquid chromatography tandem mass spectrometry methods on underivatized silica columns with aqueous/organic mobile phases. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 796: 209-224.
158. Wesnes, K.A., Ward, T., McGinty, A., and Petrini, O. 2000. The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology (Berl.). 152: 353-361.
159. White, A. 2003. Is integrated medicine respectable? Complement. Ther. Med. 11: 140-141.
160. WHO. 2003. Traditional medicine. Fact sheet No. 134 [online]. Available from http://www.who.int/mediacentre/factsheets/ fs134/en/ [cited 19 September 2004].
161. Woo, C.W., Cheung, F., Chan, V.W., Siow, Y.L., and O, K. 2003. Homocysteine stimulates inducible nitric oxide synthase expression in macrophages: antagonizing effect of ginkgolides and bilobalide. Mol. Cell. Biochem. 243: 37-47.
162. Woo, C.W., Man, R.Y.K., Siow, Y.L., Choy, P.C., Wan, E.W.Y., Lau, C.S., and O, K. 2005. Ganoderma lucidum inhibits inducible nitric oxide synthase expression in macrophages. Mol. Cell. Biochem. In Press.
163. Wright, M. 2004. An introduction to Chinese herbal medicine: with particular reference to the Chinese umbelliferae. Greenbank Pub, Edinburgh, pp. 536.
164. Wu, Y. 2002. How might qinghaosu (artemisinin) and related compounds kill the intraerythrocytic malaria parasite? A chemist's view. Acc. Chem. Res. 35: 255-259.
165. Wu, X.J., Wang, Y.P., Wang, W., Sun, W.K., Xu, Y.M., and Xuan, L.J. 2000. Free radical scavenging and inhibition of lipid peroxidation by magnesium lithospermate B. Acta Pharmacol. Sin. 21: 855-858.
166. Xiao, X., Li, F., Yuan, H., and Shi, C. 2000. An outlook on the authentication of traditional Chinese drug (TCD) by DNA molecular markers. Chin. Trad. Herbal Drugs 31(Suppl. 14): 561-564. [In Chinese.]
167. Xu, T., Zhang, H., Zhang, L., Guo, M., and Tang, K. 2003. Application of biotechnology in the quality improvement, conservation and authentication of Chinese medicine products. China Pharm. J. 38: 166-170. [In Chinese.]
168. Yamamoto, Y., Majima, T., Saiki, I., and Tani, T. 2003. Pharmaceutical evaluation of Glycyrrhiza uralensis roots cultivated in eastern Nei-Meng-Gu of China. Biol. Pharm. Bull. 26: 1144-1149.
169. Yokozawa, T., Chung, H.Y., Dong, E., and Oura, H. 1995. Confirmation that magnesium lithospermate B has a hydroxyl radical-scavenging action. Exp. Toxicol. Pathol. 47: 341-344.
170. You, Y.H., and Lin, Z.B. 2002. Protective effects of Ganoderma lucidum polysaccharides peptide on injury of macrophages induced by reactive oxygen species. Acta Pharmacol. Sin. 23: 787-791.
171. Yu, H., and Xu, L.X. 1997. Separation and determination of flavonols in the flowers of Carthamus tinctorius by RP-HPLC. Acta Pharm. Sin. 32: 120-122. [In Chinese.]
172. Zhang, Q., and Lin, Z. 1999. The antitumor activity of Ganoderma lucidum (Curt.:Fr.)P. karst. (Ling Zhi) (Aphyllophoromycetideae) polysaccharides is related to tumor necrosis factor-α and interferon-γ. Int. J. Med. Mushrooms 1: 207-215.
173. Zhang, H.N., and Lin, Z.B. 2004. Hypoglycemic effect of Ganoderma lucidum polysaccharides. Acta Pharmacol. Sin. 25: 191-195.
174. Zhang, W., Ye, Z., Yue, H., and Song, X. 2001a. Fingerprints of Radix Salviae Miltiorrhizae. Chin. Materia Med. 24: 478-480. [In Chinese.]
175. Zhang, X.Y., Zhou, D.F., Su, J.M., and Zhang, P.Y. 2001b. The effect of extract of Ginkgo biloba added to haloperidol on superoxide dismutase in inpatients with chronic schizophrenia. J. Clin. Psychopharmacol. 21: 85-88.
176. Zhang, X.Y., Zhou, D.F., Zhang, P.Y., Wu, G.Y., Su, J.M., and Cao, L.Y. 2001c. A double-blind, placebo-controlled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with schizophrenia. J. Clin. Psychiatry 62: 878-883.
177. Zhang, G.L., Wang, Y.H., Ni, W., Teng, H.L., and Lin, Z.B. 2002a. Hepatoprotective role of Ganoderma lucidum polysaccharide against BCG-induced immune liver injury in mice. World J. Gastroenterol. 8: 728-733.
178. Zhang, H., Yu, C., Jia, J.Y., Leung, S.W., Siow, Y.L., Man, R.Y., and Zhu, D. Y. 2002b. Contents of four active components in different commercial crude drugs and preparations of danshen (Salvia miltiorrhiza). Acta Pharmacol. Sin. 23: 1163-1168.
179. Zhang, W.T., He, A., and Chen, H. 2002c. Fingerprint analyses of fructus Forsythiae. China J. Chin. Materia Med. 27: 357-360. [In Chinese.]
180. Zhao, T.Z., Qin, H.L., and Liang, X.T. 2000. Authentication of traditional Chinese herbal medicines (TCHM) by 1H-NMR fingerprints. Chin. Trad. Herbal Drugs 31: 868-870. [In Chinese.]
181. Zhao, K.J., Dong, T.T., Tu, P.F., Song, Z.H., Lo, C.K., and Tsim, K.W. 2003. Molecular genetic and chemical assessment of radix Angelica (Danggui) in China. J. Agric. Food Chem. 51: 2576-2583.
182. Zhao, H.B., Lin, S.Q., Liu, J.H., and Lin, Z.B. 2004. Polysaccharide extract isolated from Ganoderma lucidum protects rat cerebral cortical neurons from hypoxia/reoxygenation injury. J. Pharmacol. Sci. 95:294-298.
183. Zheng, Y.L. 2004. Treatment of unstable angina with Flos carthami injection: Clinical observation of 30 patients. J. Emerg. Trad. Chin. Med. 13: 84. [In Chinese.]
184. Zheng, Y., and Wu, F. 2003. Advanced studies on fingerprint chromatogram of TCM. Nat. Prod. Res. Develop. 15: 55-60. [In Chinese.]
185. Zhou, W., and Ruigrok, T.J. 1990. Protective effect of danshen during myocardial ischemia and reperfusion: an isolated rat heart study. Am. J. Chin. Med. 18: 19-24.
186. Zhou, D., Zhang, X., Su, J., Nan, Z., Cui, Y., Liu, J., Guan, Z., Zhang, P., and Shen, Y. 1999. The effects of classic antipsychotic haloperidol plus the extract of Ginkgo biloba on superoxide dismutase in patients with chronic refractory schizophrenia. Chin. Med. J. (Engl. Ed.) 112: 1093-1096.
187. Zhou, Y.X., Yuan, Y.S., Gao, X., Wei, L.X., and Du, S.S. 2001. Studies on the fingerprint of radix notoginseng and its preparation. China J. Chin. Mater. Med. 26: 122-123. [In Chinese.]
188. Zhou, J., Xie, G., and Yan, X. 2003. Traditional Chinese medicines: molecular structures, natural sources, and applications. Ashgate Publ. Ltd., Aldershot, Engl. 1395 pp.
189. Zhu, Y.-P. 1998. Herbs promoting blood circulation and dissolving blood stasis. In Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic Publishers, Amsterdam. pp. 459-463.
190. Zhu, E., Wang, Z., Xu, G., Leung, H., and Yeung, H. 2001. HPLC/MS fingerprint analysis of tangshenosides. Chin. Materia Med. 24: 488-490. [In Chinese.]
191. Zhu, H., Wang, Z., Ma, C., Tian, J., Fu, F., Li, C., Guo, D., Roeder, E., and Liu, K. 2003. Neuroprotective effects of hydroxysafflor yellow A: in vivo and in vitro studies. Planta Med. 69: 429-433.